361 Capital’s Arvinas ARVN Stock Holding History

361 Capital’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$605K	Sell	18,038 -2,803	-13%	-$119K	0.28%	197
2020 Q1	$840K	Buy	+20,841	New	+$975K	0.38%	86

Other funds holding ARVN

CPI

Canaan Partners IX Menlo Park, California $87.5M AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

361 Capital's ARVN Position: Q2 2020 in Review

361 Capital reduced its Arvinas (ARVN) stake by 13% in Q2 2020, selling an estimated $119K and leaving 18,038 shares worth $605K. The position accounts for 0.28% of the portfolio, ranked #197.

361 Capital first reported a position in ARVN in Q1 2020 and has held it in 2 quarters since. The position peaked at $840K in Q1 2020. 142 funds tracked by Wall St. Rank hold ARVN as of Q2 2020.

361 Capital held 18,038 shares of Arvinas worth $605K as of Q2 2020.
361 Capital sold 2,803 Arvinas shares in Q2 2020, an estimated $119K.
Arvinas made up 0.28% of 361 Capital's portfolio in Q2 2020, its #197 holding.
361 Capital first reported a position in Arvinas in Q1 2020 and has held it in 2 quarters since.
361 Capital's Arvinas position peaked at $840K in Q1 2020.
142 funds tracked by Wall St. Rank held Arvinas as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.